2007•Cancer Genetics and CytogeneticsRequires access

A report of early cytogenetic response to imatinib in two patients with chronic myeloid leukemia at accelerated phase and carrying the e19a2 BCR-ABL transcript

Xiaoqing Li, Jing Xiang Yang, Xiangjun Chen, Jun Liu, Hongrui Li, Jine Zheng, Yanli He, Zhong Chen, Shiang Huang

Open publisher page 14 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 14 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Imatinib, Myeloid leukemia, breakpoint cluster region, Biology, Cancer research, ABL, Imatinib mesylate, Fusion gene

Back to paper search Browse research topics Original source

A report of early cytogenetic response to imatinib in two patients with chronic myeloid leukemia at accelerated phase and carrying the e19a2 BCR-ABL transcript — Research Paper | ScholarLens